Laura Andrea
Charola Ramos
Ikertzailea 2018-2021 tartean
Universidad Complutense de Madrid
Madrid, EspañaUniversidad Complutense de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2022
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
Journal of Clinical Medicine, Vol. 11, Núm. 24